NASDAQ:CRIS) share price climb by 13%. But spare a thought for the long term holders, who have held the stock as it bled value over the last five years. Indeed, the share price is down a whopping 90% in that time. While the recent increase might be a green shoot, we’re certainly hesitant to rejoice. The real question is whether the business can leave its past behind and improve itself over the years ahead.” data-reactid=”28″>This week we saw the Curis, Inc. (NASDAQ:CRIS) share price climb by 13%. But spare a thought for the long term holders, who have held the stock as it bled value over the last five years. Indeed, the share price is down a whopping 90% in that time. While the recent increase might be a green shoot, we’re certainly hesitant to rejoice. The real question is whether the business can leave its past behind and improve itself over the years ahead.
While a drop like that is definitely a body blow, money isn’t as important as health and happiness.
Check out our latest analysis for Curis ” data-reactid=”30″> Check out our latest analysis for Curis
Because Curis made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Shareholders of unprofitable companies usually expect strong revenue growth. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.
Over five years, Curis grew its revenue at 8.2% per year. That’s a fairly respectable growth rate. So the stock price fall of 14% per year seems pretty steep. The truth is that the growth might be below expectations, and investors are probably worried about the continual losses.
You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).
report on how its financial position has changed over time.” data-reactid=”50″>Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.
A Different Perspective
We’ve identified 6 warning signs with Curis (at least 3 which are concerning) , and understanding them should be part of your investment process.” data-reactid=”52″>Curis shareholders are down 54% for the year, but the market itself is up 17%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Regrettably, last year’s performance caps off a bad run, with the shareholders facing a total loss of 14% per year over five years. We realise that Baron Rothschild has said investors should “buy when there is blood on the streets”, but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. We’ve identified 6 warning signs with Curis (at least 3 which are concerning) , and understanding them should be part of your investment process.
list of growing companies that insiders are buying.” data-reactid=”53″>If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
Get in touch with us directly. Alternatively, email [email protected].” data-reactid=”55″>This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected].
